Proventus Life Science

Completed Date

2022-08-23

Sector

Healthcare

Deal Type

Company sale

Value

Not disclosed

Company bio

Proventus Life Science is engaged in the business of manufacturing, researching, developing and selling of niche Active Pharmaceutical Ingredient (API) and is supplying to regulated and semi-regulated markets with ~80% exports. The Company is present into various therapeutics including anti-epileptic, anti-fungal, anti-muscarinic and veterinary

Deal Summary

Singhi Advisors advised Proventus Life Science on its sale to Proventus Laboratories

Deal Contacts

Mahesh Singhi

Mahesh Singhi's avatar

Managing Director - Partner

mahesh@singhi.com

Sreeraj Krishnamoorthy

Sreeraj Krishnamoorthy's avatar

Vice President

sreeraj@singhi.com

Singhi Advisors Pvt. Ltd. is the exclusive Indian partner of Mergers Alliance

Other Singhi Advisors Pvt. Ltd. Deals

Other Deals

Koeleman India

Consumer

Company sale

2023-04-12

Walter Pack Automotive Products India Private Limited

Automotive and Ground Transportation

Company sale

2023-04-05

Medicentre Sonography and clinical Labs

Healthcare

Company sale

2023-03-06

Excel Controlinkage Pvt. Ltd.

Electrical Equipment

Company sale

2023-02-16